Pharmaceutical Licensing and Collaboration Agreements: Legal Considerations 2014

We have listened to your feedback!

Extensive research was undertaken with leading industry experts from both in-house counsel and private practice to ensure that we deliver the very best conference on Pharmaceutical Licensing and Collaboration Agreements: Legal Considerations. Please read on to learn more about this exciting new event.

This conference will provide an unrivalled opportunity for legal professionals to get a complete review of the most important legal decisions made over the past 12 months.

This meeting will cover the most important topics and has attracted the very best speakers in this field.

5x Keynote Presentations

Top Band Private Practice
Malcolm Bates, Partner, Taylor Wessing
Patrick Duxbury, Partner, Wragge Lawrence Graham & Co LLP
Daniel Pavin, Partner, Covington & Burling LLP
Matthew Warren, Partner, Bristows
Pat Treacy, Partner, Bristows
Gary Howes, Managing Partner, Fasken Martineau LLP
Nicola Maguire, Partner, Reed Smith LLP
Janita Good, Partner, Osborne Clarke
Vicky Clark, Consultant Solicitor, Keystone Law
Emmanuelle Trombe, Partner, Mc Dermott Will & Emery

Expert In-House Counsel
Paul Thompson, VP Legal Affairs for New Medicines and Business Development, UCB
Olivier Lemaire, Assistant General Counsel, Legal Affairs, Vaccines, GSK
Christoph Dengler, Vice President Legal, STADA Group
Gregory Jones, Associate General Counsel, Legal, Novo Nordisk A/S
Matthieu Guérineau, Contract Department Director, Les Laboratoires Servier
Torbjörn Hallberg, Senior Director and Senior Corporate Counsel, Takeda Pharmaceuticals